Pediatric dermatology: Advances in therapy

Journal of the American Academy of Dermatology

Volumn 36, Issue 4, 1997, Pages 513-530

  Chapel, K L ^a   Rasmussen, J E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ANTIFUNGAL AGENT; BENZODIAZEPINE DERIVATIVE; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CALCIPOTRIOL; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSPORIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ERYTHROMYCIN; FAMCICLOVIR; FLUCONAZOLE; GRISEOFULVIN; IMMUNOGLOBULIN; ISOTRETINOIN; ITRACONAZOLE; KETOCONAZOLE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOID; TERBINAFINE; TERFENADINE; THEOPHYLLINE; UNINDEXED DRUG; VALACICLOVIR; VIRUS DNA;

ANTIBIOTIC THERAPY; BACTERIAL SKIN DISEASE; CLINICAL TRIAL; DERMATOMYCOSIS; DRUG EFFICACY; DRUG INDICATION; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART BLOCK; HUMAN; HYPERTENSION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; TOPICAL DRUG ADMINISTRATION; TORSADE DES POINTES; VIRAL SKIN DISEASE;

EID: 0030970067     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)70238-X     Document Type: Article

References (149)

1. R Dagan Y. Bar-David Comparison of amoxicillin and clavulanic acid (Augmentin) for the treatment of nonbullous impetigo Am J Dis Child 143 1989 916 918
2. R Dagan Y. Bar-David Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of high prevalence of erythromycin-resistant Staphylococcus aureus strains Antimicrob Agents Chemother 36 1992 287 290
3. ML Misko JR Terracina DG. Diven The frequency of erythromycin-resistant Staphylococcus aureus in impetiginized dermatoses Pediatr Dermatol 12 1995 12 15
4. EF Finnerty DW. Folan Changing antibiotic sensitivities of bacterial skin diseases Cutis 23 1979 227 230
5. RR Martin V Buttram P Besch Nasal and vaginal Staphylococcus aureus in young women: quantitative studies Ann Intern Med 96 1982 951 953
6. JH. Barth Nasal carriage of staphylococci and streptococci Int J Dermatol 26 1987 24 26
7. JJ Leyde RR Marples AM. Kligman Staphylococcus aureus in the lesions of atopic dermatitis Br J Dermatol 90 1974 525 530
8. PM Mertz DA Marshall WH Eaglstein Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy Arch Dermatol 125 1989 1069 1073
9. N Ohana J Keness E Verner Skin-isolated, community-acquired Staphylococcus aureus : in vitro resistance to methicillin and erythromycin J Am Acad Dermatol 21 1989 544 546
10. GA Bohach DJ Fast RD Nelson Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses Crit Rev Microbiol 17 1990 251 272
11. J Parsonnet ZA. Gellis Production of tumor necrosis factor by human monocytes in response to toxic shock syndrome toxin-1 J Infect Dis 158 1988 1026 1033
12. DS Feingold AN. Weinberg Group A streptococcal infections: An old adversary reemerging with new tricks? Arch Dermatol 132 1996 67 70
13. PA Rehder ET Eliezer AT. Lane Perianal cellulitis Arch Dermatol 124 1988 702 704
14. JA Schneider HL. Parlette Blistering distal dactylitis: a manifestation of group A beta-hemolytic streptococcal infection Arch Dermatol 118 1982 897 898
15. DL. Stevens Invasive group A Streptococcus infections Clin Infect Dis 14 1992 2 11
16. AL Bisno DL. Stevens Streptococcal infections of the skin and soft tissue N Engl J Med 334 1996 240 245
17. TV Brogan V Nizet JHT Waldhausen A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients Pediatr Infect Dis 14 1995 588 594
18. GN Goldberg RC Hansen PJ Lynch Necrotizing fasciitis in infancy: report of three cases and review of the literature Pediatr Dermatol 2 1984 55 63
19. AM Kosloske AH Cushing TA Borden Cellulitis and necrotizing fasciitis of the abdominal wall in pediatric patients J Pediatr Surg 16 1981 246 251
20. DL. Stevens Invasive group A Streptococcus infections Clin Infect Dis 14 1992 2 11
21. HD Wilson KC. Haltalin Acute necrotizing fasciitis in childhood: report of 11 cases Am J Dis Child 125 1973 591 595
22. LD Farrell SR Karl PK Davis Postoperative necrotizing fasciitis in children Pediatrics 82 1988 874 879
23. DA Goldwag TB. Purcell Necrotizing fasciitis in the pediatric age group: report of a case J Emerg Med 8 1990 299 304
24. CJ Collette D Southerland CJ. Corrall Necrotizing fasciitis associated with Haemophilus influenzae type b Am J Dis Child 37 1987 1301 1304
25. BBW Duncan NS Adzick AA deLorimer Necrotizing fasciitis in two children with acute lymphoblastic leukemia J Pediatr Surg 27 1992 668 671
26. DL Stevens AE Gibbons R Bergstrom The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis J Infect Dis 167 1993 1401 1405
27. CG Gemmell PK Peterson D Schmeling Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin J Clin Invest 67 1981 1249 1256
28. P Yagupsky MA Menegus KR. Powell The changing spectrum of group B streptococcal disease in infants: an 11 year experience in a tertiary-care hospital Pediatr Infect Dis J 10 1991 801 808
29. RS Ramamurthy G Srinivasan NM. Jacobs Necrotizing fasciitis and necrotizing cellulitis due to group B Streptococcus Am J Dis Child 131 1977 1169 1170
30. WE Bomar JJ Ferlauto DH. Wells An unusual presentation of a beta hemolytic group B streptococcal infection J Pediatr Surg 15 1980 683 685
31. WL Weston AT Lane Color textbook of pediatric dermatology. 1991 Mosby St Louis 43 44
32. I Malinow KE. Powell Periorbital cellulitis Pediatr Ann 22 1993 241 246
33. R Raz D. Miron Oral ciprofloxacin for treatment of infection following nail puncture wounds of the foot Clin Infect Dis 21 1995 194 195
34. NP Kokx JA Comstock RR. Facklam Streptococcal perianal disease in children Pediatrics 80 1987 659 663
35. AL. Krol Perianal streptococcal dermatitis Pediatr Dermatol 7 1990 97 100
36. D Ben-Amitai S. Ashkenazi Common bacterial skin infections in childhood Pediatr Ann 22 1993 225 233
37. SE Wolverton JK. Wilkin Systemic drugs for skin diseases 1991 WB Saunders Philadelphia 59 63
38. WM Gooch III L Kaminester GW Cole Clinical comparison of cefuroxime, axetil, cephalexin and cefadroxil in the treatment of patients with primary infection of skin or skin structures Dermatologica 183 1991 36 43
39. SB. Mallory Azithromycin compared with cephalexin in the treatment of skin and skin structure infections Am J Med 91 suppl 1991 36S 39S
40. R. Kiani Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections Eur J Clin Microbiol Infect Dis 10 1991 880 884
41. R Dagan M Phillip NM. Watemberg Outpatient treatment of serious community-acquired pediatric infections using once-daily intramuscular ceftriaxone Pediatr Infect Dis J 6 1987 1080 1084
42. J. Goldfarb New antimicrobial agents Pediatr Clin North Am 42 1995 717 735
43. RP Gladue ME. Snider Intramuscular accumulation of azithromycin by cultured human fibroblasts Antimicrob Agents Chemother 34 1990 1056 1060
44. RP Gladue GM Bright RE Isaacson In vitro and in vivo uptake of azithromycin (CP 62 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection Antimicrob Agents Chemother 33 1989 277 282
45. E Eisenberg M. Barza Azithromycin and clarithromycin Curr Clin Top Infect Dis 14 1994 52 79
46. J Retsema A Girard W Schelkly Spectrum and mode of action of azithromycin (CP 62,993) a new 15-membered-ring macrolide with improved potency against Gram-negative organisms Antimicrob Agents Chemother 31 1987 1939 1947
47. R Daniel European Azithromycin Study Group Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues J Int Med Res 19 1991 433 445
48. DH Martin TF Mroczkowski ZA Dalu A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cerivicitis N Engl J Med 327 1992 921 925
49. WE Stamm CB Hicks DH. Martin Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men: a randomized double-blind study JAMA 274 1995 545 549
50. D Magid JM Douglas Jr JS. Schwartz Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis Ann Intern Med 124 1996 389 399
51. B Dautzenberg C Truffot S Legris Activity of clarithromycin against M. avium infection in patients with the acquired immune deficiency syndrome Am Rev Respir Dis 144 1991 564 567
52. P Periti T Mazzei E Mini Pharmacokinetic drug interactions of macrolides Clin Pharmacokinet 23 1992 106 131
53. RL Woosley Y Chen JP Freiman Mechanism of the cardiotoxic actions of terfenadine JAMA 269 1993 1532 1536
54. CE Stafstrom V Nohria H Loganbill Erythromycin-induced carbamazepine toxicity: a continuing problem Arch Pediatr Adolesc Med 149 1995 99 101
55. P Periti T Mazzei E Mini Pharmacokinetic drug interactions of macrolides Clin Pharmacokinet 23 1992 106 131
56. S. Hopkins Clinical toleration and safety of azithromycin Am J Med 91 1991 40S 45S
57. J Lindenbaum DG Rund VP Butler Inactivation of digoxin by the gut flora: reversal by antibiotic therapy N Engl J Med 305 1981 789 794
58. UB Schaad MA Salam Y Aujard Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission Pediatr Infect Dis J 14 1995 1 9
59. JS Wolfson DC. Hooper Overview of fluoroquinolone safety Am J Med 91 suppl 6A 1991 1535 1615
60. UB Schaad C Stoupis J Wedgwood Clinical radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin Pediatr Infect Dis J 10 1991 723 729
61. JE Burkhardt MA Hill WW Carlton Histologic and histochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin, and fluoroquinolone Vet Pathol 27 1990 162 170
62. UB Schaad J. Wedgewood Lack of quinolone-induced arthropathy in children J Antimicrob Chemother 30 1992 414 416
63. JT. Smith The mode of action of 4-quinolone and possible mechanisms of resistance J Antimicrob Chemother 18 suppl D 1986 21 29
64. R. Stahlmann Knorpelschadigende Wirking der Chinolone Infection 19 suppl 1 1991 38 46
65. G. Schluter Ciprofloxacin: toxicologic evaluation of additional safety data Am J Med 87 suppl 5A 1989 37 39
66. KM Pradham NK Arora AK Susheela Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth Acta Pediatr 84 1995 555 560
67. K Chysky R Kapila G Hullmann Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use; emphasis on joint evaluation Infection 19 1991 289 296
68. D Derse Y-C Cheng PA Furman Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate; effects on primer-template function J Biol Chem 256 1989 11447 11451
69. PA Furman MH St Clair T. Spector Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase J Biol Chem 259 1984 9575 9579
70. JJ O'Brien DM. Compoli-Richards Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties, and therapeutic efficacy Drugs 37 1989 233 309
71. H Ducoulombier J Cousin A DeWilde Herpetic stomatitis-gingivitis in children: controlled trial of acyclovir versus placebo Ann Pediatr 35 1988 212 216 [In French]
72. RJ. Whitley Herpes simplex virus infections of the central nervous system Am J Med 85 suppl 2A 1988 61 67
73. SR Preblud WA Orenstein KJ. Bart Varicella: clinical manifestations, epidemiology and health impact on children Pediatr Infect Dis J 3 1984 505 509
74. SR. Preblud Varicella: complications and costs Pediatrics 78 1986 728 735
75. MW. McKendrick Acyclovir for childhood chickenpox: cost is unjustified BMJ 310 1995 108 109
76. LM Dunkle AM Arvin RJ Whitley A controlled trial of acyclovir for chickenpox in normal children N Engl J Med 325 1991 1539 1544
77. HH Balfour Jr JM Kelly CS Suarez Acyclovir treatment of varicella in otherwise healthy children J Pediatr 116 1990 633 639
78. HH Balfour Jr HA Rotbart S Feldman Acyclovir treatment of varicella in otherwise healthy adolescents J Pediatr 120 1992 627 633
79. DI Bernstein MA Lovett YJ. Bryson The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections J Infect Dis 150 1984 7 13
80. JA Englund AM Arvin HH Balfour Jr. Acyclovir treatment for varicella does not lower gpI and IE-62(p170) antibody responses to varicella-zoster virus in normal children J Clin Microbiol 28 1990 2327 2330
81. JA Rotbart MJ Levin AR. Hayward Immune responses to varicella zoster virus in healthy children J Infect Dis 167 1993 195 199
82. S Pahwa K Biron W Lim Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS JAMA 260 1988 2879 2882
83. MA Jacobson TG Berger S Fikrig Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome Ann Intern Med 112 1990 187 191
84. NL Cole HH Balfour Jr. Varicella-zoster virus does not become more resistant to acyclovir during therapy J Infect Dis 153 1986 605 608
85. Committee on Infectious Diseases The use of oral acyclovir in otherwise healthy children with varicella Pediatrics 91 1993 674 676
86. FDA Medical Bulletin Revised label warns of severe viral problems with corticosteroids 1991;Dec: 3
87. S Weller MR Blum M Doucette Pharmacokinetics of the acyclovir prodrug, valaciclovir, after escalating single- and multiple-dose administration to normal volunteers Clin Pharmacol Ther 54 1993 595 605
88. P Easterbrook MJ. Wood Successors to acyclovir J Antimicrob Chemother 34 1994 307 311
89. MR Boyd TH Bacon D. Sutton Antiherpes activity of 9-(4-hydroxy-3-hydroxy-methyl-1-bytyl) guanine (BRL 39123) in animals Antimicrob Agents Chemother 32 1988 358 363
90. S Safrin TG Berger I Gilson Foscarnet therapyin five patients with AIDS and acyclovir-resistant varicella-zoster virus infection Ann Intern Med 115 1991 19 21
91. KJ Smith DC Kahlter C Davis Acyclovir-resistant varicella zoster responsive to foscarnet [letter] Arch Dermatol 127 1991 1069 1071
92. RJ. Whitley Sorivudine: a promising drug for the treatment of varicella-zoster virus infection Neurology 45 suppl 8 1995 S73 S75
93. H. Machida Comparison of susceptibilities of varicella-zoster virus and herpes simplex virus to nucleoside analogs Antimicrob Agents Chemother 29 1986 524 526
94. I Hardy AA Gershon SP Steinberg Varicella Vaccine Collaborative Study Group N Engl J Med 325 1991 1545 1550
95. BE. Elewski Tinea capitis: itraconazole in Trichophyton tonsurans infection J Am Acad Dermatol 31 1994 65 67
96. J Faergemann H. Maibach Griseofulvin and ketoconazole: a review with special emphasis on dermatology Semin Dermatol 6 1987 31 42
97. BE Elewski RJ. Hay International summit on cutaneous antifungal therapy, focus on tinea capitis, Boston, Massachusetts, November 11-13, 1994 Pediatr Dermatol 13 1996 69 77
98. E Presterl W. Graninger Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients: Multicentre Study Group Eur J Clin Microbiol Infect Dis 13 1994 347 351
99. HJ Degreef PRG. DeDoncker Current therapy of dermatophytosis J Am Acad Dermatol 31 1994 S25 S30
100. HB Allen PJ Hinig JJ Leyden Selenium sulfide: adjunctive therapy for tinea capitis Pediatrics 69 1992 81 83
101. SI Cullen PM. Catalano Griseofulvin-warfarin antagonism JAMA 199 1967 482 483
102. CP Van Dijke JC. Weber Interaction between oral contraceptives and griseofulvin BMJ 288 1984 1125 1126
103. DJ Back JF. Tija Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes Br J Clin Pharmacol 32 1991 624 626
104. A Ganer E Arathoon DA. Stevens Initial experience in therapy for progressive mycoses with itraconzole: the first clinically studied triazole Rev Infect Dis 9 suppl 2 1987 77 86
105. RR Tanz AA Hevert NB. Esterly Treating tinea capitis: Should ketoconazole replace griseofulvin? J Pediatr 112 1988 987 991
106. VN Gan M Petruska CM. Ginsburg Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin Pediatr Infect Dis J 6 1987 46 49
107. FC. Odds Spectrum of orally active antifungals J Eur Acad Dermatol Venereol 2 suppl 1 1993 S12 S18
108. G Cauwenbergh I Heykants R Woestenborghs Pharmacokinetic profile of orally administered itraconazole in human skin J Am Acad Dermatol 18 1988 263 268
109. S Lopez-Gomez A Del Palacio J Van Cutsem Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children Int J Dermatol 33 1994 743 747
110. R Legendre J. Esola-Macre Itraconazole in the treatment of tinea capitis J Am Acad Dermatol 23 suppl 1990 559 560
111. A Lukacs HC Korting A. Lindner Successful treatment of griseofulvin-resistant tinea capitis in infants Mycoses 37 1994 451 453
112. SM Grant SP. Clissold Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses Drugs 39 1990 877 916
113. T. Hernandez-Sampelayo Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children: Multicenter Study Group Eur J Clin Microbiol Infect Dis 13 1994 340 344
114. P Marchisio N. Principi Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole: Multicenter Study Group [erratum] Eur J Clin Microbiol Infect Dis 13 1994 694
115. Handbook of experimental pharmacology 1990 Springer-Verlag Heidelberg 483 503
116. J Faergemann H Zehender T Jones Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat Acta Derm Venereol (Stockh) 71 1991 322 326
117. TS Haroon I Hussain A Mahmood An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis Br J Dermatol 126 1992 47 50
118. NS. Ryder The mechanism of action of terbinafine Clin Exp Dermatol 14 1989 98 100
119. L. Juhlin Loss of taste and terbinafine [letter] Lancet 339 1992 1483
120. JE. Cleaver Defective repair replication of DNA in xeroderma pigmentosum Nature 218 1968 652 656
121. WB Reed B Landing G Sugarman Xeroderma pigmentosum: clinical and laboratory investigation of its basic defect JAMA 207 1969 2073 2079
122. KH Kraemer MM Lee J. Scotto Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases Arch Dermatol 123 1987 241 250
123. KH Kraemer JJ DiGiovanna AN Moshell Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin N Engl J Med 318 1988 1633 1637
124. KH Kraemer JJ DiGiovanna GL. Peck Chemoprevention of skin cancer in xeroderma pigmentosum J Dermatol 19 1992 715 718
125. AN. Moshell Prevention of skin cancer in xeroderma pigmentosum with oral isotretinoin Cutis 43 1989 485 490
126. L Edwards P. Jaffe The effect of topical tretinoin on dysplastic nevi Arch Dermatol 126 1990 494 499
127. FL Meyskens Jr. Prevention and treatment of cancerwith vitamin A and the retinoids K Prasad Vitamins, nutrition and cancer. 1984 Karger Basel 266 273
128. EL Simth NC Walworth MF. Holick Effect of 1,25-dihydorxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions J Invest Dermatol 86 1986 709 714
129. K Bhalla EP Amento B Serog 1,25-Dihydroxyvitamin D 3 inhibits antigen-induced T cell activation. J Immunol 133 1984 1747 1754
130. HP Koeffler K Hirgik L Itrik 1,25-Dihydroxyvitamin D 3 : in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep 69 1985 1399 1407
131. A Highton J. Quell Calcipotriene 0.005% for psoriasis: a safety and efficacy study J Am Acad Dermatol 32 1995 67 72
132. K. Kragballe Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC903) Arch Dermatol 125 1989 1647 1652
133. CR Darley WJ Cunliffe J Ferguson Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris [abstract] Br J Dermatol 129 suppl 42 1993 33
134. 3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children Eur J Pediatr 152 1993 389 392
135. 3 ) for treating psoriasis in children [letter] Arch Dermatol 131 1995 961 962
136. GP Lucker PCM Van de Kerkhof MR Van Dijk Effect on topical calcipotriol on congenital ichthyoses Br J Dermatol 131 1994 546 550
137. K Kragballe PM Steijlen HH Ibsen Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization Arch Dermatol 131 1995 556 560
138. HC Hoeck G Laurberg P. Laurberg Hypercalcaemic crisis after excessive topical use of a vitamin D derivative J Intern Med 235 1994 281 282
139. JF Bourke J Berth-Jones R Mumford High dose topical calcipotriol consistently reduces serum parathyroid hormone levels Clinical Endocrinol 41 1994 295 297
140. J Berth-Jones JF Bourke SJ Iqbal Urine calcium excretion during treatment of psoriasis with topical calcipotriol Br J Dermatol 129 1993 411 414
141. A Sansome V. Dubowitz Intravenous immunoglobulin in juvenile dermatomyositis: four year review of nine cases Arch Dis Child 72 1995 25 28
142. JL Lundblad N Londeree G. Mitra Characteristics of various intravenous immunoglobulin preparations J Infect 15 1987 3 12
143. JM Lusher I. Sarrier Use of intravenous gamma-globulin in children and adolescents with idiopathic thrombocytopenic purpura and other immune thrombocytopenias Am J Med 83 suppl 4A 1987 10 16
144. A. Newland Idiopathic thrombocytopenic purpura and IgG J Infect 15 1987 41 49
145. JM Oleske EM Connor MD Grebenau Treatment of HIV infected infants and children Pediatr Ann 17 1988 332 339
146. K. Sullivan Immunoglobulin therapy in bone marrow transplantation Am J Med 83S 1987 34 45
147. A Suzuki T Kamiya N Kuwahara Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases Pediatr Cardiol 7 1986 3 9
148. ST. Shulman IVGG therapy in Kawasaki disease: mechanism(s) of action Clin Immunol Immunopathol 53 1989 S141 S146
149. JW Newburger M Takahashi JC Burns The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 1987 341 347